DNA X, Inc.
Price Action
Technical Summary
CONSOLIDATINGDNA X, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 57), indicating performance broadly in line with the market. Earnings contraction of 41% provides fundamental context to the price action. However, price is extended 23% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.88 | +16.88% | ABOVE |
| 50 SMA | $4.62 | +23.39% | ABOVE |
| 100 SMA | $4.53 | +25.77% | ABOVE |
| 150 SMA | $4.74 | +20.22% | ABOVE |
| 200 SMA | $6.54 | -12.79% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SONM in an uptrend right now?
SONM has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is SONM overbought or oversold?
SONM's RSI (14) is 50. The stock is in neutral territory, neither overbought nor oversold.
Is SONM outperforming the market?
SONM has a Relative Strength (RS) Rating of 57 out of 99. SONM is performing about average compared to the market.
Where is SONM in its 52-week range?
SONM is trading at $5.70, which is 21% of its 52-week high ($26.82) and 13% above its 52-week low ($2.52).
How volatile is SONM?
SONM has a Beta of 0.51 and 52-week volatility of 128%. It's less volatile than the S&P 500 - generally more stable.